Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02260869 · ClinicalTrials.gov registry record · NA
Efficacy of Cooled and Monopolar Radiofrequency Ablation of the Geniculate Nerves for the Treatment of Chronic Osteoarthritic Knee Pain
A NA study, sponsored by Millennium Pain Center.
- Terminated
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT02260869 is a NA study that was terminated before completion, run by Millennium Pain Center. The registered enrollment target is 79 participants.
The verdict
NCT02260869, a NA study, was terminated before completion, sponsored by Millennium Pain Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
This is a single center randomized controlled trial. Approximately 102 patients will be randomized to one of two treatment groups: cooled radiofrequency or conventional monopolar radiofrequency ablation. Patients with chronic knee pain, with moderate to severe osteoarthritis according to the Kellgren-Lawrence scale for at least 6 months who have failed conservative therapy will be screened for the study. Then, patients will be enrolled based on reporting ≥50% pain relief after a fluoroscopic guided single diagnostic block of the geniculate nerves (superior medial, superior lateral, and inferior medial) with 0.5 ml of local anesthetic (2% Lidocaine). Baseline data will be collected for all enrolled patients. Outcomes will be measured at 1, 4, 12, 24 and 52 weeks. Outcome measures will be: Visual analogue scale (VAS) both while at rest and during ambulation, Oxford knee scores, WOMAC, and global perceived effect.
Interventions
- PROCEDURE Genicular nerve radiofrequency ablation
- DEVICE Pain Management Radiofrequency Kit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2015-01 |
| Est. Completion | 2019-06-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02260869
The ClinicalTrials.gov registry entry for NCT02260869 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Millennium Pain Center, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Genicular nerve radiofrequency ablation is the first listed.
NCT02260869 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02260869 about?
NCT02260869 is a clinical study titled "Efficacy of Cooled and Monopolar Radiofrequency Ablation of the Geniculate Nerves for the Treatment of Chronic Osteoarthritic Knee Pain". This is a single center randomized controlled trial. Approximately 102 patients will be randomized to one of two treatment groups: cooled radiofrequency or conventional monopolar radiofrequency ablation. Patients with chronic knee pain, with moderate to severe osteoarthritis according to the Kellgre...
What is the current status of trial NCT02260869?
This trial is currently terminated. It is a NA study. The enrollment target is 79 participants. The study started on 2015-01. Estimated completion is 2019-06-26.
What interventions are being tested in trial NCT02260869?
The interventions under investigation include: Genicular nerve radiofrequency ablation (PROCEDURE), Pain Management Radiofrequency Kit (DEVICE).
Who is sponsoring clinical trial NCT02260869?
This trial is sponsored by Millennium Pain Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.